QQ客服 官方微博 反馈留言

	Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial
	Perng, Wann Cherng; Chuang, Yin Ching; Wu, Xiaoju; Xiao, Yi; Shen, Ce; Li, Qimangu; Wan, Yixin; Huang, Wenxiang; Lin, Qichang; Li, Jianguo
刊名	JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
	2019
卷号	52期号:1
关键词	Clinical outcome Community-acquired pneumonia Levofloxacin Nemonoxacin Randomized controlled trial Safety
ISSN号	1684-1182
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3631821
专题	上海中医药大学
推荐引用方式 GB/T 7714	Perng, Wann Cherng,Chuang, Yin Ching,Wu, Xiaoju,et al. Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial[J]. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,2019,52(1).
APA	Perng, Wann Cherng.,Chuang, Yin Ching.,Wu, Xiaoju.,Xiao, Yi.,Shen, Ce.,...&Tsao, Shih-Ming.(2019).Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial.JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION,52(1).
MLA	Perng, Wann Cherng,et al."Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial".JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION 52.1(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。